ACCELERATE DIAGNOSTICS INC (AXDX)

US00430H2013 - Common Stock

0.9248  -0.02 (-1.82%)

After market: 0.98 +0.06 (+5.97%)

Full profile views are only available for registered users, you can see which data is available below.

Examples of complete profiles are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional data.

ACCELERATE DIAGNOSTICS INC

NASDAQ:AXDX (5/3/2024, 7:00:01 PM)

After market: 0.98 +0.06 (+5.97%)

0.9248

-0.02 (-1.82%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
Chartmill FA Rating
Valuation
Growth
Profitability
Health
Dividend
Overview
Earnings (Last)
Earnings (Next)
Ins Owners
Inst Owners
Market Cap20.03M
Shares
PEN/A
Fwd PEN/A
Dividend YieldN/A
Analysts
IPO
Stock Screener Links
Screen Image

Nasdaq Stock Screener

Find more stocks on Nasdaq

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

AXDX Daily chart

Company Profile

Accelerate Diagnostics Inc is a US-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in Denver, Colorado and currently employs 179 full-time employees. Accelerate Diagnostics, Inc. is an in-vitro diagnostics company. The firm is engaged in providing solutions that improve patient outcomes through the diagnosis of serious infections. Its in-vitro diagnostic platform, the Accelerate Pheno system utilizes genotypic technology to identify (ID), infectious pathogens and phenotypic technology to conduct antibiotic susceptibility testing (AST), which determines whether live bacterial or fungal cells are resistant or susceptible to a particular antibiotic. The company detects and identifies pathogens directly from a single patient sample followed by antimicrobial susceptibility testing based on the identification results. The Accelerate Pheno system features walk-away automation and consists of a fixed instrument and single-use test kit. The Accelerate PhenoTest BC Kit, in conjunction with other clinical and laboratory findings, in the diagnosis of bacteremia and fungemia, both life-threatening conditions with high morbidity and mortality risk.

Company Info

ACCELERATE DIAGNOSTICS INC

3950 S Country Club Rd Ste 470 Bldg 3-307

Denver COLORADO 85714

P: 13038638088

CEO: Jack Phillips

Employees: 179

Website: http://acceleratediagnostics.com/

AXDX News

News Image2 days ago - Accelerate Diagnostics, Inc.Accelerate Diagnostics Scheduled Call to Review 2024 First Quarter Results.

/PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ: AXDX) announced today that management will host a conference call on Wednesday, May 8, 2024, at 4:30 p.m....

News Imagea month ago - InvestorPlaceAXDX Stock Earnings: Accelerate Diagnostics Misses EPS, Misses Revenue for Q4 2023

AXDX stock results show that Accelerate Diagnostics missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023.

News Imagea month ago - BusinessInsiderAXDX Stock Earnings: Accelerate Diagnostics Misses EPS, Misses Revenue for Q4 2023

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Accelerate Diagnostics (NASDAQ:AXDX) just reported results for the fourth quart...

News Imagea month ago - Accelerate Diagnostics, Inc.Accelerate Diagnostics Reports Fourth Quarter and Full-Year 2023 Financial Results

/PRNewswire/ -- Accelerate Diagnostics, Inc. (Nasdaq: AXDX) today announced financial results for the fourth quarter and year ended December 31, 2023. "In...

News Image2 months ago - Accelerate Diagnostics, Inc.Accelerate Diagnostics Scheduled Call to Review 2023 Fourth Quarter and Full Year Results.

/PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ: AXDX) announced today that management will host a conference call on Thursday, March 28, 2024, at 4:30...

News Image4 months ago - Seeking AlphaAccelerate Diagnostics prices $15M public offering and private placement, shares fall

Accelerate Diagnostics (NASDAQ:AXDX) said Friday it priced an underwritten public offering of units and a concurrent private placement to raise up to $15...

AXDX Twits

Here you can normally see the latest stock twits on AXDX, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example